Remove 2017 Remove FDA Remove Prescription Filling
article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

The FDA Law Blog

A red flag does not prohibit a pharmacist from filling a prescription but is a potential concern with the prescription that the pharmacist must address and resolve. If the pharmacist can resolve it, they must make a record of the resolution. Complaint ¶ 55.

article thumbnail

Three strategies for managing loss of exclusivity successfully

pharmaphorum

In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. 10 Since FDA approval in 1998 the ‘Little Blue Pill’ had some of the fastest prescription uptakes and sales growth of any medication, bringing in $400 million in revenue in its first quarter after launch and going on to produce annual sales of about $1.8

article thumbnail

Ozempic statistics 2025

The Checkup by Singlecare

Ozempic was approved by the Food and Drug Administration (FDA) in 2017 for the treatment of Type 2 diabetes. In 2020, the FDA approved Ozempic for reducing the risk of heart attack, stroke, or death in adults with Type 2 diabetes with known heart disease. FDA , 2025) How much do Americans spend on Ozempic?